The offering is priced at a deep discount ($0.07/share) and represents substantial dilution. Monitor the company's cash burn and ability to execute on its stated use of proceeds. The stock is likely to face downward pressure as the market absorbs the new shares.
Price Chart
Executive Summary
NewGenIVF Group priced a public offering of approximately $1.25 million in gross proceeds, selling 17.86 million ordinary shares or pre-funded warrants at $0.07 per share. The proceeds will be used for investment in K25.ai, debt restructuring, working capital, and general corporate purposes. This highly dilutive offering (relative to the company's market cap) signals urgent cash needs and is bearish for existing shareholders.
Key Financial Metrics
Key Facts
- Gross proceeds of approximately $1.25 million from a public offering of 17,857,143 ordinary shares or pre-funded warrants.
- Public offering price per share is $0.07 (pre-funded warrants at $0.06999).
- Proceeds to be used for investment in K25.ai, debt restructuring, working capital (including Nodexus machines), and general corporate purposes.
- Offering expected to close on or about September 30, 2026.
- Aegis Capital Corp. is the exclusive placement agent.
Financial Impact
Approximately $1.25 million gross proceeds; highly dilutive given the low share price and large number of shares offered relative to likely market cap.
Risk Factors
- Severe dilution to existing shareholders from the 17.86 million new shares/warrants.
- Use of proceeds includes debt restructuring and working capital, indicating potential financial distress.
- Low offering price ($0.07) suggests weak demand and potential further capital needs.
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3370369 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | 6-K | $0.1884 $0.1489 | ▼ −20.97% | ▼ −19.79% | $1.16 (+515.71%) |
Oct 7, 2026 19d ago | 6-K | $0.0811 $0.0721 | ▲ +11.10% | ▲ +11.70% | $1.16 (−1330.33%) |
Oct 7, 2026 19d ago | 6-K | $0.1060 $0.0811 | ▼ −23.49% | ▼ −23.07% | $1.16 (+994.34%) |
Oct 6, 2026 20d ago | SC 13D/A | $0.0987 $0.1060 | ▲ +7.40% | ▲ +7.64% | $1.16 (+1075.28%) |
Oct 5, 2026 21d ago | 6-K | $0.1100 $0.0987 | ▲ +10.27% | ▲ +10.82% | $1.16 (−954.55%) |
Sep 30, 2026 26d ago | Press Release | $0.1680 $0.1010 | ▲ +39.88% | ▲ +40.06% | $1.16 (−590.48%) |
Sep 30, 2026 26d ago | 424B4 | $5.38 $3.23 | ▲ +39.88% | ▲ +40.06% | $1.16 (+78.42%) |
Sep 29, 2026 27d ago | EFFECT | $0.0720 $0.1680 | ▼ −133.33% | ▼ −133.54% | $1.16 (−1511.11%) |
Sep 28, 2026 28d ago | Press Release | $0.0720 $0.1680 | ▼ −133.33% | ▼ −133.54% | $1.16 (−1511.11%) |
Sep 2, 2026 7w ago | Insider Cluster | $1.21 $1.18 | ▼ −2.48% | ▼ −3.53% | $1.16 (−4.13%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers